D. Antonadou

1.5k total citations
32 papers, 1.2k citations indexed

About

D. Antonadou is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, D. Antonadou has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Oncology. Recurrent topics in D. Antonadou's work include Effects of Radiation Exposure (10 papers), Brain Metastases and Treatment (9 papers) and Advanced Radiotherapy Techniques (9 papers). D. Antonadou is often cited by papers focused on Effects of Radiation Exposure (10 papers), Brain Metastases and Treatment (9 papers) and Advanced Radiotherapy Techniques (9 papers). D. Antonadou collaborates with scholars based in Greece, United States and Venezuela. D. Antonadou's co-authors include N. Throuvalas, M. Synodinou, P. Karageorgis, N. Coliarakis, M. Paraskevaidis, George E. Sarris, Maria Ausiliatrice Puglisi, I. Economou, H. Athanassiou and K. Beroukas and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

D. Antonadou

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Antonadou Greece 12 784 383 380 376 185 32 1.2k
N. Throuvalas Greece 9 580 0.7× 331 0.9× 194 0.5× 284 0.8× 167 0.9× 27 837
M. Synodinou Greece 10 519 0.7× 179 0.5× 220 0.6× 354 0.9× 181 1.0× 24 844
Bahman Emami United States 14 704 0.9× 329 0.9× 179 0.5× 261 0.7× 100 0.5× 25 1.0k
P. Karageorgis Greece 7 572 0.7× 305 0.8× 370 1.0× 209 0.6× 41 0.2× 18 789
B. Parashar United States 17 420 0.5× 179 0.5× 184 0.5× 173 0.5× 68 0.4× 47 876
Mitsuhiro Takemoto Japan 17 533 0.7× 315 0.8× 71 0.2× 136 0.4× 75 0.4× 66 947
Arndt‐Christian Müller Germany 21 659 0.8× 184 0.5× 66 0.2× 390 1.0× 46 0.2× 71 1.1k
Günther Klautke Germany 19 467 0.6× 605 1.6× 75 0.2× 71 0.2× 77 0.4× 69 1.0k
Kazuo Kubota Japan 14 400 0.5× 313 0.8× 96 0.3× 401 1.1× 16 0.1× 64 1.1k
Hiromichi Ishiyama Japan 21 881 1.1× 259 0.7× 26 0.1× 190 0.5× 72 0.4× 103 1.3k

Countries citing papers authored by D. Antonadou

Since Specialization
Citations

This map shows the geographic impact of D. Antonadou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Antonadou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Antonadou more than expected).

Fields of papers citing papers by D. Antonadou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Antonadou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Antonadou. The network helps show where D. Antonadou may publish in the future.

Co-authorship network of co-authors of D. Antonadou

This figure shows the co-authorship network connecting the top 25 collaborators of D. Antonadou. A scholar is included among the top collaborators of D. Antonadou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Antonadou. D. Antonadou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mell, Loren K., Renuka Malik, Ritsuko Komaki, et al.. (2007). Effect of Amifostine on Response Rates in Locally Advanced Non–Small-Cell Lung Cancer Patients Treated on Randomized Controlled Trials: A Meta-Analysis. International Journal of Radiation Oncology*Biology*Physics. 68(1). 111–118. 27 indexed citations
2.
Antonadou, D.. (2005). Current Treatment of Brain Metastases. European Oncology & Haematology. 1–1. 4 indexed citations
3.
Throuvalas, N., D. Antonadou, Robert S. Lavey, Mourad Boufi, & N. Malamos. (2004). Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors. International Journal of Radiation Oncology*Biology*Physics. 60(1). S300–S300. 4 indexed citations
4.
Throuvalas, N., et al.. (2004). Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors. International Journal of Radiation Oncology*Biology*Physics. 60. S300–S300. 1 indexed citations
5.
Athanassiou, H., M. Synodinou, M. Paraskevaidis, et al.. (2004). Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study. International Journal of Radiation Oncology*Biology*Physics. 60(1). S162–S163. 2 indexed citations
6.
Athanassiou, H., D. Antonadou, N. Coliarakis, et al.. (2003). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial. International Journal of Radiation Oncology*Biology*Physics. 56(4). 1154–1160. 79 indexed citations
7.
Antonadou, D., et al.. (2003). Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer. Seminars in Oncology. 30(6 Suppl 18). 2–9. 24 indexed citations
8.
Antonadou, D., et al.. (2003). Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non–small-cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 57(2). 402–408. 69 indexed citations
9.
Antonadou, D., N. Coliarakis, M. Paraskevaidis, et al.. (2003). 777 A multi-institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus radiotherapy alone. European Journal of Cancer Supplements. 1(5). S234–S234. 3 indexed citations
10.
Antonadou, D., H. Athanassiou, George E. Sarris, et al.. (2003). 1087 Randomized phase III trial of chemoradiation treatment amifostine in patients with colorectal cancer. European Journal of Cancer Supplements. 1(5). S325–S325. 1 indexed citations
11.
Antonadou, D., et al.. (2003). 926 Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors. European Journal of Cancer Supplements. 1(5). S279–S279. 1 indexed citations
12.
Antonadou, D., et al.. (2002). Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. International Journal of Radiation Oncology*Biology*Physics. 52(3). 739–747. 183 indexed citations
13.
Antonadou, D., N. Coliarakis, M. Paraskevaidis, et al.. (2002). Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study. International Journal of Radiation Oncology*Biology*Physics. 54(2). 93–94. 37 indexed citations
14.
Antonadou, D., et al.. (2001). Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer. International Journal of Radiation Oncology*Biology*Physics. 51(4). 915–922. 154 indexed citations
15.
Antonadou, D., et al.. (2001). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. European Journal of Cancer. 37. S358–S358. 2 indexed citations
16.
Antonadou, D., et al.. (2001). Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study. European Journal of Cancer. 37. S144–S144. 38 indexed citations
17.
Paraskevaidis, Evangelos, et al.. (2000). A phase III randomized trial of synchronous radiotherapy with temozolomide in brain metastases. International Journal of Radiation Oncology*Biology*Physics. 48(3). 114–114. 1 indexed citations
18.
19.
Antonadou, D., M. Synodinou, Panagiotis Iliopoulos, Michail Katsoulis, & N. Throuvalas. (1995). 1190 Combined radiotherapy and immunotherapy in advanced stages of cancer of the uterine cervix. European Journal of Cancer. 31. S248–S248. 1 indexed citations
20.
Makrigiorgos, G. Mike, et al.. (1990). . Physics in Medicine and Biology. 35(1). 139–145. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Throuvalas Breakdown of academic impact, for papers by M. Synodinou Breakdown of academic impact, for papers by Bahman Emami Breakdown of academic impact, for papers by P. Karageorgis Breakdown of academic impact, for papers by B. Parashar Breakdown of academic impact, for papers by Mitsuhiro Takemoto Breakdown of academic impact, for papers by Arndt‐Christian Müller Breakdown of academic impact, for papers by Günther Klautke Breakdown of academic impact, for papers by Kazuo Kubota Breakdown of academic impact, for papers by Hiromichi Ishiyama
Rankless by CCL
2026